Willow vs Henry Meds
$399/mo against $449/mo for tirzepatide. Which is worth it, and for whom.
Updated 2026-09-18
DISCLOSURE — Coreage Rx pays this desk a commission when a reader signs up through our link. It buys no ranking, no score and no deletions. Method: how we rate. Full terms: disclosure.
Both sell tirzepatide. Willow costs $399 a month and Henry Meds costs $449, a difference of $50 a month or about $600 a year. The desk reads it as follows.
Willow is straightforward single-price plans. Henry Meds is sublingual and oral formats. They are not aimed at the same person, and the cheaper one is not automatically the right answer — though on this board it usually is.
Advert against bill. Willow advertises $399 and bills $399; Henry Meds advertises $399 and bills $449. The gaps are different sizes, which means comparing the two on their advertised prices gives you the wrong answer.
Side by side
| Willow | Henry Meds | |
|---|---|---|
| Advertised from | $399 | $399 |
| Membership on top | None | None |
| True monthly cost | $399 | $449 |
| Roughly, per year | $4,788 | $5,388 |
| Price includes medication | Yes | Yes |
| Names its pharmacy | Not published | Not published |
| Our score | 2.9 / 5 | 3 / 5 |
Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.
The split
They differ on 1 of the 7 things we track, and behave the same on the other 6. The differences are what the price gap is actually buying.
| Willow | Henry Meds | |
|---|---|---|
| Offers an oral or sublingual option | No | Yes |
What each puts on the record: Willow
- Compounded tirzepatide listed at $399/month.
Where it wins: A single price with no membership arithmetic. Watch for: There is little published detail on how dose changes are handled. Ask before committing.
What each puts on the record: Henry Meds
- Injectable tirzepatide listed at $399 for the first month and $449/month recurring.
- Oral tirzepatide tablets listed at $299 first month, $349/month recurring.
- Compounded semaglutide injection around $297/month; sublingual around $249/month with a $179/month tier.
- Three-month oral tirzepatide supply $1,047, or $891 paid in full.
- Three-month oral semaglutide supply $747, or $537 paid in full.
- Advertising states pricing "starts at $179/month", which corresponds to the lowest sublingual tier.
Where it wins: No membership fee layered on top of medication. Watch for: The advertised "starts at $179" is the sublingual tier. Weekly injectable tirzepatide renews at $449/month.
In each one’s favour
Willow.
- A single price with no membership arithmetic.
Henry Meds.
- No membership fee layered on top of medication.
- Real choice of sublingual, oral tablet and injection.
How they score
| What we weigh | Weight | Willow | Henry Meds |
|---|---|---|---|
| True monthly cost | 30% | 2.4 | 2.3 |
| Price honesty | 20% | 3 | 2.8 |
| Clinical support | 20% | 3.1 | 3.7 |
| Pharmacy sourcing | 15% | 3.1 | 3.6 |
| Cancelling | 15% | 3 | 2.9 |
Henry Meds scores higher overall at 3 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.
The desk’s call
- Pick Willow if cost is the binding constraint. Over a year the gap is about $600, which is real money for the same class of medication.
- Pick Henry Meds if what it does better matters to you — no membership fee layered on top of medication.
- Ask both which pharmacy compounds the medication and whether it is a 503A or 503B facility. Neither publishes it.
The verdict
On the board, Willow at $399 a month is the more defensible choice on arithmetic alone. Henry Meds earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: Willow and Henry Meds.
How they sit against everyone else
| Programme | Advertised | Billed | Gap | Vs board floor |
|---|---|---|---|---|
| Coreage Rx | $149 | $199 | +$50 | +$74/mo |
| Trimi | $125 | $125 | none | — |
| Ozari Health | $125 | $125 | none | — |
| Fifty 410 | $133 | $133 | none | +$8/mo |
| PlexusDx | $129 | $189 | +$60 | +$64/mo |
| Ivím Health | $199 | $199 | none | +$74/mo |
| Zealthy | $216 | $216 | none | +$91/mo |
| Hims & Hers | $199 | $238 | +$39 | +$113/mo |
| Coby Health | $179 | $239 | +$60 | +$114/mo |
| Mochi Health | $199 | $278 | +$79 | +$153/mo |
| Eden | $199 | $298 | +$99 | +$173/mo |
| Lemonaid Health | $229 | $348 | +$119 | +$223/mo |
More from the desk
- Willow tirzepatide review
Advertised at $399 and billed at $399 — no gap. Position 15 of 18 on our board.
- Henry Meds tirzepatide review
Advertised at $399, billed at $449. Position 18 of 18 on our board.
- How to spot a bad seller
The FDA sent more than 55 warning letters to online GLP-1 sellers in one day. Here is how to tell a licensed programme from the rest.
- The twelve-month cost
Month one is the cheapest month you will have. Here is the full-year arithmetic, including the costs nobody puts in the advert.
- Cheapest right now
Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $149/mo semaglutide.